Leadership move unites clinical trial expertise with strategic vision to drive next phase of growth for the clinical trial marketing agency.
Stark / Raving Health today announced the appointment of André Briola, MPH, as Senior Director of Growth. An accomplished healthcare executive, Briola brings over 15 years of expertise in clinical operations and patient recruitment to drive the agency’s next phase of expansion.
Briola joins Stark / Raving Health from his role as Senior Director of Growth at Publicis Health, which acquired BBK Worldwide in 2022. At BBK, he advanced from Director of Strategic Consultation to Senior Director of Growth, where he led strategic planning, patient recruitment, and operations across programs of all scales, from specialized rare disease studies to complex global trials. His strategic leadership accelerated clinical trial enrollment by streamlining patient recruitment processes and introducing innovative patient engagement approaches.
“We’re absolutely thrilled to welcome André to the Stark / Raving Health family,” said Matthew Stumm, President of Stark / Raving Health. “His extraordinary talent for transforming operational challenges into growth opportunities strengthens our position as a global leader in clinical trial marketing and patient recruitment. André’s dynamic leadership style and proven ability to deliver exceptional results make him the perfect catalyst for our next phase of growth.”
As Senior Director of Growth, Briola will spearhead the agency’s ambitious expansion initiatives while reimagining its approach to market development and strategic partnerships. In this pivotal role, he will leverage his expertise to identify new revenue streams and optimize existing service lines. His proven track record of building high-performing teams will be instrumental in scaling the company’s operations while maintaining exceptional quality standards.
“Throughout my career, I’ve seen firsthand how integrating strategic insight, patient-centric creative, and data-driven media dramatically accelerates patient recruitment,” said Briola. “I’m excited to join the exceptional team at Stark / Raving Health, where my experience will help scale operations. The company’s sophisticated approach is elevating clinical trial engagement across global markets, and I look forward to helping drive this momentum forward.”
Briola’s deep understanding of clinical research and development stems from his distinguished career at leading medical institutions. His experience spans prestigious roles in clinical research and institutional review boards at Boston’s Tufts-New England Medical Center and Children’s Hospital Boston. His international expertise was shaped through senior positions at Anahuac University School of Medicine and La Raza Medical Center in Mexico City, where he honed his comprehensive approach to clinical operations and patient care.
About Stark / Raving Health
Stark / Raving Health combines clinical trial expertise, award-winning creativity, and sophisticated media strategies to accelerate global patient recruitment. Operating in over 50 countries and 70 languages, we drive enrollment success through our unique blend of therapeutic insight and digital innovation. This powerful approach has established us as the trusted partner for leading biotechs, pharmaceutical companies, and CROs transforming clinical trials through strategic, patient-inspired campaigns.
To learn more, visit www.starkravinghealth.com
.